Dr. Alexis M Megaludis - NPI #1942271648

Hematologist & Oncologist located in Washington, PA

Pennsylvania Washington Hematology & Oncology Dr. Alexis M Megaludis Information


Dr. Alexis M Megaludis is a female Hematologist & Oncologist (taxonomy code 207RH0003X) located in Washington, Pennsylvania. Dr. Alexis M Megaludis's NPI Number is #1942271648 and has been listed in the NPI registry for 10 years. Dr. Alexis M Megaludis's practice location is listed as: 997 N Main St Suite 2 Washington, PA 15301-2819 and can be reached via phone at (724) 223-3816.

Hematology & Oncology Taxonomy

The taxonomy code for Dr. Alexis M Megaludis's main specialty, Hematology & Oncology, is 207RH0003X. An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.



Be the first to rate Dr. Megaludis

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1942271648
 Phone (724) 223-3816
 Fax (724) 223-4079
997 N Main St
Suite 2
Washington, PA 15301-2819
 Gender F
 Website Not provided
  • Hematology & Oncology (PA)
Business Information
  • Sole Proprietor? No
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 9/18/2007
 Added 1/30/2006
 Viewed on 10/26/2016
Health Care Providers Nearby

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.